https://www.scmp.com/business/companies/article/3338728/insilico-signs-us888-million-ai-drug-development-deal-days-after-hong-kong-ipo?module=top_story&pgtype=section
Jan 5, 2026 - Multi-year partnership with France’s Servier will use Insilico’s AI platform to explore novel cancer drugs.
drug developmentinsilicosignsusmillion
https://www.scmp.com/business/banking-finance/article/3338086/insilico-medicine-leads-sextet-hong-kong-ipos-capping-banner-year-fundraising?module=top_story&pgtype=subsection
Dec 30, 2025 - Debutants raise total of US$899 million as exchange wraps up one of the most active months for IPOs since 2021.
insilico medicinehong kongleadsiposcapping
https://observer.com/2025/09/interview-alex-zhavoronkov-insilico-drug-discovery-ai/
Sep 18, 2025 - Insilico CEO Alex Zhavoronkov on A.I.-driven drug discovery, clinical validation and the rise of pharmaceutical superintelligence.
drug discoveryinsilicoalextalksobserver
https://insilico.com/pandaomics
Expand your horizons of OMICs data analysis and visualization
insilico medicine
https://www.scmp.com/business/china-business/article/3209246/hong-kong-ai-firm-insilico-aramco-partner-development-sustainable-fuels-and-materials?module=top_story&pgtype=subsection
Dec 19, 2025 - AI drug discovery unicorn Insilico Medicine is set to sign a deal with Saudi Arabia’s Aramco and a subsidiary during Hong Kong leader John Lee Ka-chiu’s...
hong kongexclusiveaifirminsilico
https://insilico.com/
Generative AI and Automation for Longevity and Sustainability
insilico medicinemain
https://www.asiabusinessoutlook.com/news/insilico-medicine-signs-888m-ai-cancer-drug-deal-with-servier-nwid-10997.html
Insilico Medicine has entered into a strategic partnership with French pharmaceutical major Servier in a deal valued at up to US$888 million, just days after...
insilico medicinesignsaicancerdrug
https://www.capgemini.com/insights/expert-perspectives/capgemini-and-insilico-medicine-partnering-to-accelerate-ai-powered-drug-discovery/
Sep 30, 2025 - Capgemini and Insilico Medicine: Partnering to Accelerate AI-Powered Drug Discovery
insilico medicineai poweredcapgeminipartneringaccelerate
https://fprimecapital.com/company/insilico-medicine/
Jan 5, 2026 - Insilico specializes in artificial intelligence for drug discovery, biomarker development and aging research.
insilico medicinefprimecapital
https://insilico.com/chemistry42
Harness the power of Generative AI and Physics-based methods
insilico medicine
https://blogs.nvidia.com/blog/insilico-medicine-uses-generative-ai-to-accelerate-drug-discovery/
Oct 16, 2024 - The startup, a premier member of NVIDIA Inception, is entering Phase 2 clinical trials with a drug candidate discovered using its AI platform.
insilico medicinegenerative aidrug discoveryusesaccelerate
https://www.scmp.com/business/banking-finance/article/3199001/sanofi-signs-research-tie-hong-kongs-insilico-medicine-accelerate-ai-powered-drug-discovery?module=top_story&pgtype=subsection
Dec 19, 2025 - French pharmaceutical giant Sanofi will collaborate with Hong Kong-based biotech firm Insilico Medicine in a deal worth up to US$1.2 billion to speed up the...
insilico medicinesanofisignsresearchtie